Medicare Will Pay $50K For Your Heart Attack. It Should Pay $100 To Prevent It.

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

The ACC and AHA’s March 2026 prevention guidelines give coronary artery calcium scans a central role for adults with borderline or intermediate risk when the decision about preventive medication is uncertain. The opinion article argues that Medicare and other insurers should pay for the roughly $100 test, but the source does not establish a new Medicare coverage policy or confirm what Medicare pays for a heart attack.

The American College of Cardiology and American Heart Association gave coronary artery calcium scans a more central role in their March 2026 heart disease prevention guidelines, recommending the tests for some adults whose risk is borderline or intermediate and whose decision about preventive treatment remains uncertain. The change, described by two physicians in an October 25 opinion article, puts renewed focus on whether insurers, including Medicare, will cover a scan the authors say costs about $100.

A coronary artery calcium, or CAC, scan is a brief imaging test that detects calcified plaque in the arteries. The authors, cardiologists Arthur Agatston and Oren Mechanic, say it takes about 10 minutes and uses a fraction of the radiation of a standard chest CT. They describe it as a way to detect coronary atherosclerosis before it causes symptoms or a heart attack.

The guidelines recommend considering CAC imaging when a person has borderline or intermediate estimated risk and the decision to begin preventive treatment, such as a statin, is not settled. A score of zero can help move a risk assessment downward; a score above 100 may indicate that medication and more intensive lifestyle measures are worth discussing. The scan informs a clinical decision; it does not by itself determine a treatment plan.

Agatston and Mechanic illustrate the point with a 52-year-old patient, identified by a changed name, whose standard risk estimate was low but whose scan showed a score of 220. The authors say the result altered the prevention discussion. This is an example from their practice, not evidence that CAC screening will change outcomes for every patient or that the scan is appropriate for everyone.

The Cost of Prevention Coverage

The authors’ central argument is about how health care pays for prevention. They contrast a scan they estimate costs about $100 with a heart attack that they say can cost $50,000 to treat, arguing that payment rules can discourage a test that might help identify disease earlier. Those figures are the authors’ framing; the article does not provide a Medicare payment schedule or a detailed comparison of costs across patients and settings.

For patients, coverage can affect whether a clinician can offer imaging as part of a risk discussion or whether the patient must pay out of pocket. The guideline change may give clinicians a clearer basis for considering CAC in selected cases, but it does not itself require Medicare or private insurers to cover the scan. The distinction matters: a recommendation in clinical guidance is not the same as a coverage decision.

The authors also point to AI analysis of existing chest CT scans as a possible way to spot calcification without ordering a separate scan. They say such tools could help identify people who might benefit from follow-up, including those less able to pay for elective imaging. Wider use would depend on reliable reporting, clinical follow-up and payment arrangements; the opinion piece does not establish how broadly those systems are operating.

How CAC Entered Prevention Guidance

Doctors commonly use risk calculators based on factors such as age, sex, cholesterol, diabetes, blood pressure and smoking to estimate a person’s chance of cardiovascular disease. The authors argue that these estimates do not show whether an individual already has plaque. CAC imaging adds information about calcified plaque, which may help when a risk estimate alone does not settle whether to start treatment.

According to the opinion article, CAC evidence accumulated over more than three decades, while the test remained a peripheral option in national guidance. The authors attribute the lag partly to clinical systems designed around population-level risk factors, cautious guideline processes and insurance coverage limits. They say that, in practice, some patients have had to pay directly for the scan.

The article’s headline contrasts a $50,000 heart attack bill with a $100 preventive scan, but it is an argument for changing payment priorities, not an announcement that Medicare has adopted those prices or coverage terms. The reported guideline update is the specific development: CAC now has a more prominent role for a defined group of adults facing an uncertain treatment decision.

“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”

— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their MedPage Today opinion article

Coverage and Outcomes Still Unsettled

The source does not say whether Medicare currently covers CAC scans for the patients described in the guidelines, whether coverage differs by plan or clinical circumstances, or whether Medicare has announced a new payment policy. It also does not document that a heart attack routinely costs $50,000 or establish that paying for scans would produce net savings.

The guideline recommendation is limited to adults with borderline or intermediate risk when a preventive treatment decision remains uncertain. The article does not provide new trial results, population-level outcomes or evidence that routine scanning of all adults would prevent heart attacks. The patient example is illustrative, and the extent to which AI can reliably identify clinically relevant plaque from existing scans remains unspecified in the source.

How Coverage May Respond

The immediate next step is for health systems, clinicians and insurers to apply the March guideline recommendation to eligible patients and clarify whether CAC testing is covered under particular plans. Patients considering a scan can ask their clinician whether it would change a treatment decision and check with their insurer about costs before proceeding.

The article does not identify a scheduled Medicare decision or a forthcoming policy deadline. Further developments to watch include coverage determinations, how clinicians incorporate CAC results into care, and whether AI review of existing CT scans is used with clear standards for reporting and follow-up.

Key Questions

What changed in the March 2026 heart prevention guidelines?

The ACC and AHA gave CAC scans a more central role for adults with borderline or intermediate cardiovascular risk when the decision about preventive treatment remains uncertain.

Does the article confirm that Medicare will pay for a CAC scan?

No. It argues that Medicare and other insurers should support prevention, but does not report a new Medicare coverage decision or specify current coverage terms.

What does a CAC scan measure?

It detects calcified plaque in the coronary arteries. Clinicians may use the result alongside other information when discussing cardiovascular risk and preventive treatment.

Does a score of zero mean someone has no heart disease?

The authors say a zero score can reclassify risk downward. The article does not say it rules out all coronary disease or replaces an individual medical assessment.

Is the $50,000 heart attack cost a confirmed Medicare figure?

No. The figure is part of the authors’ cost comparison in the opinion article. The source does not provide a Medicare payment schedule or establish a typical treatment cost.

Source: rss